4//SEC Filing
Quimi Daphne 4
Accession 0000950170-24-070769
CIK 0001658551other
Filed
Jun 6, 8:00 PM ET
Accepted
Jun 7, 4:42 PM ET
Size
5.3 KB
Accession
0000950170-24-070769
Insider Transaction Report
Form 4
Quimi Daphne
Director
Transactions
- Award
Stock Option (right to buy)
2024-06-06+25,000→ 25,000 totalExercise: $1.76Exp: 2034-06-05→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]The shares subject to this option shall vest in full upon the earlier of (i) June 6, 2025 or (ii) the date of the next annual meeting, subject to the Reporting Person's continuous service to the Issuer through such vesting date.
Documents
Issuer
Amylyx Pharmaceuticals, Inc.
CIK 0001658551
Entity typeother
Related Parties
1- filerCIK 0001543031
Filing Metadata
- Form type
- 4
- Filed
- Jun 6, 8:00 PM ET
- Accepted
- Jun 7, 4:42 PM ET
- Size
- 5.3 KB